Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma

Translational Research

Volumn 168, Issue , 2016, Pages 134-145

  Kamel, Marwa M ^a   Matboli, Marwa ^a   Sallam, Maha ^a   Montasser, Iman F ^a   Saad, Amr S ^a   El Tawdi, Ahmed H F ^b  

^a AIN SHAMS UNIVERSITY   (Egypt)

^b MILITARY MEDICAL ACADEMY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; BIOLOGICAL MARKER; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA UROTHELIAL CARCINOMA ASSOCIATED 1; LONG UNTRANSLATED RNA WD REPEAT CONTAINING ANTISENSE TO TP53; UNCLASSIFIED DRUG; TELOMERASE; TELOMERASE CAJAL BODY PROTEIN 1, HUMAN; TRANSCRIPTOME; TUMOR MARKER; UCA1 RNA, HUMAN;

ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHRONIC HEPATITIS C; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE EXPRESSION; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RECURRENCE FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; BLOOD; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RNA, LONG NONCODING; TELOMERASE; TRANSCRIPTOME;

EID: 84973439789     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2015.10.002     Document Type: Article

References (31)

1. 1 Stewart BW & Wild CP In Liver cancer, World Cancer Report 2014 (IARC, 2014).
2. 2 Park, Y.N., Update on precursor and early lesions of hepatocellular carcinomas. Arch Pathol Lab Med 135 (2011), 704–715.
3. 3 National Cancer Registry of Egypt. Magnitude of hepatocellular carcinoma in Egypt. 2010 Available at: http://www.nci.cu.edu.eg [updated 2010 August 6].
4. 4 El-Serag, H.B., Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 37:Suppl 2 (2007), S88–S94.
5. 5 Bruix, J., Sherman, M., Management of hepatocellular carcinoma: an update. Hepatology 53 (2011), 1020–1022.
6. 6 Esteller, M., Non-coding RNAs in human disease. Nat Rev Genet 12 (2011), 861–874.
7. 7 Ling, H., Fabbri, M., Calin, G.A., MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov 12 (2013), 847–865.
8. 8 Huang, J.L., Zheng, L., Hu, Y.W., et al. Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis 35 (2014), 507–514.
9. 9 Prensner, J.R., Chinnaiyan, A.M., The emergence of lncRNAs in cancer biology. Cancer Discov 1 (2011), 391–407.
10. 10 Ishibashi, M., Kogo, R., Shibata, K., et al. Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep 29 (2013), 946–950.
11. 11 Lai, M.C., Yang, Z., Zhou, L., et al. Long noncoding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29 (2012), 1810–1816.
12. 12 Zhang, L., Yang, F., Yuan, J.H., et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 34 (2013), 577–586.
13. 13 Du, Y., Kong, G., You, X., et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J Biol Chem 287 (2012), 26302–26311.
14. 14 Llovet, J.M., Brú, C., Bruix, J., Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999), 329–338.
15. 15 Child, C.G., Turcotte, J.G., Surgery and portal hypertension. Major Probl Clin Surg 1 (1964), 1–85.
16. 16 Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973), 646–649.
17. 17 Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta deltaC(T)) method. Methods 25 (2001), 402–408.
18. 18 Chatterjee, R., Mitra, A., An overview of effective therapies and recent advances in biomarkers for chronic liver diseases and associated liver cancer. Int Immunopharmacol 24 (2015), 335–345.
19. 19 Gibb, E.A., Brown, C.J., Lam, W.L., The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 10, 2011, 38.
20. 20 Morris, K.V., Long antisense non-coding RNA function to direct epigenetic complexes that regulate transcription in human cells. Epigenetics 4 (2009), 296–301.
21. 21 Halaby, M.J., Yang, D.Q., p53 translational control: a new facet of p53 regulation and its implication for tumorigenesis and cancer therapeutics. Gene 395 (2007), 1–7.
22. 22 Hung, T., Wang, Y., Lin, M.F., et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat. Genet 43 (2011), 621–629.
23. 23 Martínez-Ló pez, N., Varela-Rey, M., Fernández-Ramos, D., et al. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis. Hepatology 52 (2010), 1621–1631.
24. 24 Wang, Y., Chen, W., Yang, C., et al. Long non-coding RNA UCA1 (CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int J Oncol 41 (2012), 276–284.
25. 25 Huang, J., Zhou, N., Watabe, K., et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis, 5, 2014, e1008.
26. 26 Han, Y., Yang, Y.N., Yuan, H.H., et al. UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution. Pathology 46 (2014), 396–401.
27. 27 Wang, F., Ying, H., He, B., et al. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 6 (2015), 7899–7917.
28. 28 Rui-Guo, W., Yuan, S., Qing, L., et al. DNA damage-induced lncRNA-UCA1 promotes HeLa cell proliferation. Chinese J Biochem Mol Biol 31 (2015), 505–513.
29. 29 Katayama, S., Tomaru, Y., Kasukawa, T., et al. Antisense transcription in the mammalian transcriptome. Science 309 (2005), 1564–1566.
30. 30 Mahmoudi, S., Henriksson, S., Corcoran, M., et al. Wrap53, anaturalp53 antisense transcript required for p53 induction upon DNA damage. Mol Cell 33 (2009), 462–471.
31. 31 Wright, C.M., Kirschner, M.B., Cheng, Y.Y., et al. Long non coding RNAs (lncRNAs) are dysregulated in malignant pleural mesothelioma (MPM). PLoS One, 8, 2013, e70940.